National Bank of Greece announces cash tender offers for MREL notes

Pavlos Mylonas CEO
Pavlos Mylonas CEO
0Comments

National Bank of Greece SA has announced the launch of voluntary cash tender offers for its €500,000,000 2.750% Green Fixed Rate Resettable Unsubordinated MREL Notes due 2026 and £200,000,000 8.750% Fixed Rate Resettable Unsubordinated MREL Notes due 2027. The announcement was made in accordance with Regulation (EU) 596/2014 and Greek law 3556/2007.

The bank intends to issue a series of new euro-denominated unsubordinated MREL notes under its €5,000,000,000 Global Medium Term Note Programme. These new notes are expected to be admitted to trading on the Luxembourg Stock Exchange.

Acceptance of any notes tendered is conditional upon the successful issuance of the new notes. Settlement for both the tender offers and the new notes is anticipated to occur on the same day.

BofA Securities Europe SA, Deutsche Bank Aktiengesellschaft, Goldman Sachs Bank Europe SE, HSBC Continental Europe, Intesa Sanpaolo S.p.A., Morgan Stanley Europe SE, and Société Générale are acting as dealer managers for these offers.

“This announcement does not constitute an invitation to participate in the Tender Offers or the New Notes in any jurisdiction in which, or to or from any person to or from whom, it is unlawful to make such invitation under applicable securities laws,” stated the bank. The distribution of this announcement may be restricted by law in certain jurisdictions.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.